The easiest way to acquire a 12-lead ECG, making critical data accessible in more places, more often.
Learn how Kardia 12L can transform your practice.
HCPs may be eligible for a 2-week trial.
Apply NowFor healthcare professional use only
Reimagining the 12-Lead ECG Experience
We challenged our engineers, clinicians, and data scientists to rethink the 12-lead ECG.
The resulting technology underscores our commitment to transform cardiovascular care — simplifying and expediting access to critical cardiac data.
Patients
Practices
Instances of myocardial infarction and ischemia detected
One-cable design + AI trained with one million ECGs.
The FDA-cleared Kardia 12L is an AI-powered handheld 12-lead resting ECG system. With simplified leadset technology, Kardia 12L offers outstanding clinical efficiency that expands access to 12-lead recordings in more settings than ever before.
Its unique single-cable design makes lead placement more intuitive and less error-prone, so even qualified personnel with infrequent ECG experience can acquire an accurate recording in minutes.
And with 1 million ECGs from leading U.S. medical institutions, our team developed a robust algorithm with multiple deep neural network AI models. The Kardia 12L ECG algorithm received FDA 510(k) clearance by demonstrating substantial equivalence to the state-of-the-art 12-lead ECG algorithm.
See the 35 FDA-cleared determinations it can detect.
See HowRecent data presented at Heart Rhythm Society 2024, "Diagnostic accuracy of a mobile, artificial intelligence-guided, 12-lead ECG device," showed results from a clinical study on 200 patients. See the side-by-side ECG reports from a standard 12-lead compared to one from the Kardia 12L for the same patients.
The study found that Kardia 12L enabled rapid acquisition of resting ECG information, and concluded "this approach has significant implications for rapid ECG diagnosis in clinical practice."
The poster can be accessed here.
Standard 12-lead ECG vs. Kardia 12L ECG report
The KardiaStation app, compatible with most smartphones and tablets, guides users in selecting one of two lead set placement options depending on patient symptoms.
From KardiaStation, record a 12-lead ECG with just five electrodes. Providing eight standard diagnostic-bandwidth leads, it synthesizes the remaining four leads.
It can detect 35 determinations (14 arrhythmias and 21 morphologies) — including acute myocardial infarction (MI) and the most common types of cardiac ischemia. See full list below.
Recordings from the app can easily be sent to colleagues for quick review. Patient data are automatically uploaded to the KardiaPro® web portal, a secure and streamlined platform to manage and review patient ECG history.
Kardia 12L may be eligible for reimbursement through CME or professional development funds. Check your employer's policy for eligibility.
Kardia 12L may be eligible for reimbursement using your HSA/FSA funds. Check with your plan administrator for details.
Contact our team to book a demo.
Or download the guide for more information.
Legal
1Whyte, Seabrook, et al. "Diagnostic accuracy of a mobile, artificial intelligence-guided, 12-lead ECG device." Poster presented at: Heart Rhythm Society 2024; May 16-19, 2024; Boston MA, USA.
2The provisional automated ECG analysis should not be used for clinical action if it has not been reviewed by a healthcare professional qualified to independently interpret the ECG signal. The four synthesized chest leads are not intended for diagnostic use
Kardia 12L is intended for use with patients aged 18 years and older. Kardia 12L is intended for use by healthcare professionals, or trained personnel in healthcare facilities (e.g. the doctor's office or hospital) and in acute settings.
